Financial

Actuate Therapeutics Announces Poster Presentations at the 2023 AACR Annual Meeting

CHICAGO and FORT WORTH, Texas, April 10, 2023 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (Actuate), a clinical stage biopharmaceutical company,…

1 year ago

Predictive Oncology Announces Appointment of Oncology Translational Research Leader Christoph Reinhard, Ph.D., MBA, to its Scientific Advisory Board

EAGAN, Minn., April 04, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a science-driven company leveraging its proprietary artificial intelligence…

1 year ago

OMNIMED™ Announces Integration of SmartOR™ Into Axis Research & Technologies Facilities

Roll-Out Across National Bioskills Training Centers Gives Med Device Companies and Surgeons Access to Intelligent Data-Driven Technology Platform and AI…

1 year ago

Healthcare Triangle Expands Long-Standing Customer Engagement with readabl.ai Medical Document Automation Solution

readabl.ai is a best-in-class AI and language processing model that help customers achieve maximum performance efficiency in workflow automationPLEASANTON, Calif.,…

1 year ago

Mydecine Reports Financial Results for the Year Ended December 2022

DENVER, March 31, 2023 (GLOBE NEWSWIRE) -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) ("Mydecine" or the "Company"),…

1 year ago

Transplant Logistics Leader MediGO Issues Statement Welcoming HRSA Announcement on Organ Procurement and Transplantation Network Modernization Initiative

BALTIMORE, March 30, 2023 (GLOBE NEWSWIRE) -- MediGO, a Baltimore-based digital healthcare supply chain technology company focused on improving equity,…

1 year ago

Predictive Oncology Announces Collaboration with Integra Therapeutics to Advance Gene Therapy

EAGAN, Minn., March 30, 2023 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a science-driven company on the leading edge of oncology…

1 year ago

OMNIMED Introduces New National Director of Technology

Medical technology company grows leadership team with promotion of Christian Loversky OMNIMED Introduces New National Director of Technology OMNIMED™, the medical…

1 year ago

Onconova Therapeutics and Pangea Biomed Enter into Research Collaboration to Identify Biomarkers of Response to Rigosertib

Collaboration builds off clinical data demonstrating rigosertib’s activity against PLK1 and may inform a precision medicine approach towards rigosertib’s evaluation…

1 year ago

Evaxion presents a new source of AI-derived immunotherapeutic targets strongly associated with the overall survival of cancer patients

Evaxion’s AI technology has led to the identification of new viral targets for cancer immunotherapyThis potentially enables treatment for patients…

1 year ago